단백질분해효소 억제제 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "단백질분해효소 억제제" in Korean language version.

refsWebsite

Global rank Korean rank

6nih.gov

4^th place

5doi.org

2^nd place

3^rd place

1cdc.gov

218^th place

52^nd place

1aacrjournals.org

8,869^th place

4,351^st place

aacrjournals.org

clincancerres.aacrjournals.org

J.J. Gills; 외. (2007). “Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo”. 《Clinical Cancer Research》 13 (17): 5183–94. doi:10.1158/1078-0432.CCR-07-0161. PMID 17785575.

cdc.gov

“HIV Surveillance --- United States, 1981--2008”. 2013년 11월 8일에 확인함.

doi.org

dx.doi.org

Dunn LA; Andrews KT; McCarthy JS; 외. (2007). “The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis”. 《Int. J. Antimicrob. Agents》 29 (1): 98–102. doi:10.1016/j.ijantimicag.2006.08.026. PMID 17137752.
Andrews KT; Fairlie DP; Madala PK; 외. (2006). “Potencies of Human Immunodeficiency Virus Protease Inhibitors In Vitro against Plasmodium falciparum and In Vivo against Murine Malaria”. 《Antimicrob. Agents Chemother.》 50 (2): 639–48. doi:10.1128/AAC.50.2.639-648.2006. PMC 1366900. PMID 16436721.
J.J. Gills; 외. (2007). “Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo”. 《Clinical Cancer Research》 13 (17): 5183–94. doi:10.1158/1078-0432.CCR-07-0161. PMID 17785575.
Pyrko, P.; Kardosh, A; Wang, W; Xiong, W; Schönthal, AH; Chen, TC (2007). “HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress”. 《Cancer Research》 67 (22): 10920–8. doi:10.1158/0008-5472.CAN-07-0796. PMID 18006837.
Fantry, LE (2003). “Protease inhibitor-associated diabetes mellitus: A potential cause of morbidity and mortality”. 《Journal of Acquired Immune Deficiency Syndromes》 32 (3): 243–4. doi:10.1097/00126334-200303010-00001. PMID 12626882.

nih.gov

ncbi.nlm.nih.gov

Dunn LA; Andrews KT; McCarthy JS; 외. (2007). “The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis”. 《Int. J. Antimicrob. Agents》 29 (1): 98–102. doi:10.1016/j.ijantimicag.2006.08.026. PMID 17137752.
Andrews KT; Fairlie DP; Madala PK; 외. (2006). “Potencies of Human Immunodeficiency Virus Protease Inhibitors In Vitro against Plasmodium falciparum and In Vivo against Murine Malaria”. 《Antimicrob. Agents Chemother.》 50 (2): 639–48. doi:10.1128/AAC.50.2.639-648.2006. PMC 1366900. PMID 16436721.
J.J. Gills; 외. (2007). “Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo”. 《Clinical Cancer Research》 13 (17): 5183–94. doi:10.1158/1078-0432.CCR-07-0161. PMID 17785575.
Pyrko, P.; Kardosh, A; Wang, W; Xiong, W; Schönthal, AH; Chen, TC (2007). “HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress”. 《Cancer Research》 67 (22): 10920–8. doi:10.1158/0008-5472.CAN-07-0796. PMID 18006837.
Fantry, LE (2003). “Protease inhibitor-associated diabetes mellitus: A potential cause of morbidity and mortality”. 《Journal of Acquired Immune Deficiency Syndromes》 32 (3): 243–4. doi:10.1097/00126334-200303010-00001. PMID 12626882.
Capaldini, L. (1997). “Protease inhibitors' metabolic side effects: cholesterol, triglycerides, blood sugar, and "Crix belly"”. 《AIDS Treatment News》 (277): 1–4. PMID 11364559.